David Wainer
Healthcare Columnist, Heard on the Street at The Wall Street Journal
Columnist @WSJ Heard on the Street @WSJheard
Articles
-
1 week ago |
wsj.com | David Wainer
Tariffs are certainly getting pharma CEOs to listen, and many are already stockpiling imports while expanding production within existing U.S. sites. That is in order to avoid steep penalties on their profit-shifting strategies as the Trump administration conducts a probe into pharmaceuticals in a bid to impose levies on the sector. But changes to the tax code could prove even more crucial to long-term investment.
-
1 week ago |
finance.yahoo.com | David Wainer
No matter how high President Trump cranks up tariffs, many industries are never coming back to the U.S. For industries that require cheap labor such as apparel and toys, bringing that production to Pennsylvania or Ohio just doesn’t make sense. For pharma, an industry in which gross margins are among the highest in the S&P 500, labor was never really the reason for moving offshore to places like Ireland—it was always about playing the global tax game.
-
1 week ago |
finance.yahoo.com | David Wainer
Johnson & Johnson has plans to enlarge its U.S. footprint. - Associated Press No matter how high President Trump cranks up tariffs, many industries are never coming back to the U.S. For industries that require cheap labor such as apparel and toys, bringing that production to Pennsylvania or Ohio just doesn’t make sense.
-
2 weeks ago |
livemint.com | David Wainer
Novo Nordisk sparked the obesity drug revolution with Ozempic and Wegovy. Now it’s racing to avoid falling further behind Eli Lilly. On Monday, Novo announced new partnerships with telehealth providers Hims & Hers Health, Ro, and LifeMD to sell its weight-loss drug Wegovy through their platforms. Hims & Hers, for instance, will dispense all doses of Wegovy to Americans who sign up for eligible subscriptions, with plans starting at $599 a month.
-
2 weeks ago |
wsj.com | David Wainer
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed byour Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contactDow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/novo-nordisk-ozempic-eli-lilly-c7ac45ae
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 6K
- DMs Open
- Yes
RT @WSJ: 🧵On March 29, 2023, Wall Street Journal reporter Evan Gershkovich was detained in Russia for doing his job. He remains in a Russi…
It has been six months since Evan was wrongfully imprisoned. Enough is enough. Evan did nothing wrong. Let him go. #IStandWithEvan https://t.co/UMAISFlgP2
RT @WSJPR: Tomorrow, September 29, will mark six months since Evan Gershkovich was wrongfully detained by Russia. Join @WSJ and the broader…